Health & Biotech
MGC Pharmaceuticals (ASX: MXC) has changed its name to Argent Biopharma - RGT (ASX: RGT).
Below are the previous articles from MGC Pharmaceuticals (ASX: MXC):
RELATED STOCKHEAD STORIES
News
CEOs look back and share their company highlights from 2021
News
CEOs look back and share the most important lesson they learnt in 2021
Health & Biotech
What you’ve been vaping for: MGC Pharma now has the first-ever Cannabinoid vape available as an unapproved therapeutic good for use in Australia
Health & Biotech
MGC Pharma secures $10m capital raise from US and UK investors to advance development for its lead drug candidate, CimetrA
Health & Biotech
As Biotron more than doubles on promising COVID results, which other ASX stocks are working on treatments?
Health & Biotech
MGC Pharma set for best half-yearly results after delivering ArtemiC order in Europe
Health & Biotech
MGC Pharma US partnership validated after receiving first payment for US$24m order of CimetrA
Health & Biotech
ASX Health Stocks: Paradigm rockets 21pc after getting FDA nod, Memphasys up 31pc on imminent launch
Health & Biotech
MGC Pharma opens new production facility in Malta, now set to ramp up sales of CimetrA
Health & Biotech
ASX Health Stocks: Intelicare jumps 35pc on AI in-home sensor tech contract for seniors
Health & Biotech
With record growth in 2021, MGC Pharma’s Q1 trading update confirmed it’s laid the foundation for a global expansion
Health & Biotech
MGC Pharma lands milestone US$3 million CimetrA purchase order
Health & Biotech
MGC Pharma receives first order in the US, as it seeks to fast track commercialisation of CimetrA
Health & Biotech
Here’s why this fundie expects MGC Pharma’s stock price to more than double
Health & Biotech
MGC Pharma makes inroads in the fight against COVID-19, getting a regulatory nod in Germany and a successful trial in India
Health & Biotech
ASX Health Stocks: M&A winds blow as API gets an upgraded offer from Wesfarmers, jumps 15pc
Health & Biotech
